This amendment provides $393,801 the second year from the general fund to develop a new data collection program to address prescription drug price transparency, pursuant to the provisions of House Bill 2007, 2021 Special Session I. The data would be used in combination with data already submitted to the Virginia All Payer Claims Database (APCD) to develop an annual online report that analyzes drivers of prescription drug prices. The legislation requires information that cannot be collected using the existing APCD layout and data fields. Costs decrease in the out-years to $318,801 annually after subtracting one-time costs for the development of the system.